Brief: Cytodyn Submits Top-Line Report From Phase 2 Covid-19 Trial To FDA And Requests Emergency Use Approval

Cytodyn

17/08/2020 11:07

Aug 17 (Reuters) - Cytodyn Inc  CYDY.PK :
    * CYTODYN SUBMITS ITS TOP-LINE REPORT FROM ITS PHASE 2
COVID-19
TRIAL TO THE U.S. FDA AND REQUESTS EMERGENCY USE APPROVAL
    * CYTODYN INC - PREPARING A PHASE 3 PROTOCOL FOR LERONLIMAB
USE IN
LONG-HAULER COVID-19 INDIVIDUALS
    * CYTODYN - TOP-LINE REPORT SENT TO REGULATORY AUTHORITIES
IN
MEXICO, TO BE PROVIDED TO U.K. MHRA, & E.U. EMA, WITH REQUESTS
FOR EMERGENCY USE APPROVAL

Source text for Eikon:  ID:nGNX8HjGmB 
Further company coverage:  CYDY.PK 

 ((Reuters.Briefs@thomsonreuters.com;))